Cambridge website for Synthetic Biology Resources
 
synbio logo2_100a

Compiled by Jim Haseloff at the University of Cambridge
This site contains details of recent papers and activity in Synthetic Biology, with particular emphasis on: (i) development of standards in biology and DNA parts, (ii) microbial and (iii) plant systems, (iv) research and teaching in the field at the University of Cambridge, (v) hardware for scientific computing and instrumentation, (vi) tools for scientific productivity and collected miscellany. 

 

www.synbio.org.uk

SpannerPlantLogo70 logoplate70  

SynBio calendar

  • 18 Feb

    Technology is driving revolutionary changes in biology. Over the past decade, scientists and engineers have begun to define the path forward in the genomic era. Systems Biology has arisen...

  • 17 Mar

    Now that we know the sequences of many genomes, from a wide variety of organisms and even from individuals with unique characteristics, many researchers have turned to making intentional...

  • 09 Apr

    The developments within synthetic biology promise to change the world in significant ways. Yet synthetic biology is largely unrecognized within conservation. The purpose of the meeting...

  • 09 Jun

    (Re-)constructing and Re-programming Life This conference will provide an in-depth discussion forum among practitioners of the various fields underlying Synthetic Biology. It aims to...

  • 09 Jul

    The BioBricks Foundation is pleased to announce The BioBricks Foundation Synthetic Biology 6.0 Conference (SB6.0), which will take place on July 9-11, 2013 at Imperial College, London,...

  • 30 Jul

    This course will focus on how the complexity of biological systems, combined with traditional engineering approaches, results in the emergence of new design principles for synthetic...

18 Feb - 23 Mar
09 Apr - 15 Jun
09 Jul - 13 Aug

SynBio Google newsfeed

Loading...
Synbio news:
19 Mar 2012

The flavors and fragrance (F&F) market seem to be benefiting from renewable chemicals developments from players such as Amyris, Allylix and Blue Marble Biomaterials...and chemical firms also supplying the F&F market are taking notice.

BASF announced on Monday that its venture capital business has invested $13.5m in Allylix, which BASF said allows them to leverage their aroma chemicals, nutrition and cosmetic chemicals competency. BASF is one of the biggest global producer of aroma chemicals by the way.

According to a study released last year by US accounting firm Marcum LLP and the Samuel Curtis Johnson Graduate School of Management at Cornell University, the market for aroma chemicals and essential oils are [either] both a rapidly expanding market segment [or] and a highly profitable product segment.

"The highest growth companies in the study, those that experienced over 6% growth year-over-year, generated 20% of their overall revenue from the sale of aroma chemical and essential oils while "low-growth" companies (those with 1-2% growth year-over-year) generated half as much of their revenue from this product segment."

Meanwhile, US market research firm Freedonia reported that the US market for F&F is forecast to rise 3%/year to $5.5bn in 2014. Among the major product segments, essential oils and natural extracts are projected to achieve the most rapid gains.


US FLAVORS & FRAGRANCES DEMAND
(million dollars)
% Annual Growth
2004
2009
2014
2004-2009
2009-2014
Flavor & Fragrance Demand
3910
4750
5500
4.0
3.0
Food
1436
1740
1990
3.9
2.7
Cosmetics & Toiletries
980
1270
1500
5.3
3.4
Cleaning Products
500
570
650
2.7
2.7
Environmental Fragrance Goods
397
470
560
3.4
3.6
Beverages
364
430
500
3.4
3.1
Other
233
270
300
3.0
2.1

© 2011 by The Freedonia Group, Inc.

 


Back to Allylix, the company said it will soon launch its rare and highly valuable terpene that is structurally related to beta-vetivone, one of the key component of vetiver oil - an essential oil. Beta-vetivone has never been commercialized because it cannot be produced synthetically in a cost-effective process, according to Allylix.

Trademarked Epivone, Allylix' product is expected to gain annual  revenue between $20m and $200m based on revenues for similar terpene molecules used in fragrance applications.

Allylix expects to start production of Epivone in commercial quantities in the third quarter 2012 in applications such as cologne, hair care and personal care fragrance.

Allylix bags BASF investment

(Via ICIS Green Chemicals.)

PhD Studies in Cambridge

The Board of Graduate Studies manages admission of the University's graduate students. Prospective students should start here - for an introduction to the University of Cambridge, the courses we offer, how to apply for postgraduate study, how your application will be processed, and immigration and other important information.

Click here for more information about Cambridge

 

Weather in Cambridge

°F°C
CAMBRIDGE
invalid location provided